Device for treating malignant diseases with the help of tumor-destructive mechanical pulses (tmi)
AssigneeTissue Regeneration Technologies, LLC
InventorsAxel Erich Theuer, Irmengard Theuer, John David Mullins
Life of this patent
Estimating the term…
Abstract
A device and a method, which is individual to a patient, treat malignant diseases by using selectively acting tumor-destructive mechanical pulses (TMI). The tumor-destructive pulse shapes and frequency are determined using physical cell properties, which are individual to each patient. The device is controlled in such that lethal pulse fields are applied in the tumor area.
Claims23
A method for selective destruction of malignant cells in a target volume of a living organism, comprising
- activating at least one shockwave generator of a treatment device for enabling shockwaves to be emitted from at least one applicator of the treatment device, wherein said activating includes setting a prescribed delay time between temporally successive shockwaves, wherein the prescribed delay time is determined as a function of an extension characteristic of said malignant cells and healthy cells within the target volume, and wherein the prescribed delay time precludes said healthy cells within the target volume from achieving a lethal level of extension in response to exposure to said shockwaves prior to said malignant cells reaching a lethal level of extension;
- and
- applying, via the at least one shockwave applicator, a plurality of shockwaves into the target volume, wherein said applying in accordance with the prescribed delay time causes a current one of said shockwaves to be applied to the target volume while said malignant cells therein remain in a state of extension caused by an immediately prior one of said shockwaves applied to the target volume thereby enabling said malignant cells to reach the lethal level of extension through extension build-up caused by successive impulse fields.
A treatment device for selective destruction of malignant cells in a target volume of a living organism, comprising
- at least one applicator;
- at least one shockwave generator connected to the at least one applicator for enabling shockwaves to be emitted therefrom;
- and
- at least one control unit connected to the at least one shockwave generator for enabling operative control of the at least one shockwave generator and the at least one applicator connected thereto, wherein said operative control includes:
- activating the at least one shockwave generator, wherein said activating includes setting a prescribed delay time between temporally successive shockwaves, wherein the prescribed delay time is determined as a function of an extension characteristic of said malignant cells and healthy cells within the target volume, and wherein the prescribed delay time precludes said healthy cells within the target volume from achieving a lethal level of extension in response to exposure to said shockwaves prior to said malignant cells achieving a lethal level of extension;
- and
- outputting, via the at least one shockwave applicator, a plurality of shockwaves into the target volume, wherein said outputting in accordance with the prescribed delay time causes a current one of said shockwaves to be applied to the target volume while said malignant cells therein remain in a state of extension caused by an immediately prior one of said shockwaves applied to the target volume thereby enabling said malignant cells to reach the lethal level of extension through extension build-up caused by successive impulse fields.
Dependencies are inferred from the claim text.